RecruitingNCT01670695
A Prospective Cohort Study of IgG4RD in China
Cohort Study of Patients With IgG4-Related Disease
Sponsor
Peking Union Medical College Hospital
Enrollment
1,000 participants
Start Date
Jan 1, 2012
Study Type
OBSERVATIONAL
Conditions
Summary
This is an cohort study to investigate the disease course and treatment response of patients with IgG4-related disease.
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with igg4-related disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01670695
Related Trials
Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases
NCT062855396 locations
The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA.
NCT075355541 location
Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease
NCT070619383 locations
A Study of Efgartigimod in Patients With IgG4-Related Disease
NCT070253301 location
A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease
NCT070681651 location